Regulus Therapeutics Logo Image

Regulus Therapeutics

Regulus Therapeutics Banner Image

Most Recent Annual Report

2016 Annual Report and Form 10K

Regulus Therapeutics

Regulus Therapeutics has reached its limit for free report views.

Regulus Therapeutics does not currently have any hardcopy reports on AnnualReports.co.uk. Click the button below to request a report when hardcopies become available.

Archived Annual Reports

About Regulus Therapeutics

51-200 Employees
Based in San Diego, California

Regulus Therapeutics Inc. (NASDAQ:RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a well-balanced microRNA therapeutics pipeline complemented by a maturing microMarkersSM biomarkers platform and a rich intellectual property estate to retain its leadership in the microRNA field.

Ticker:
RGLS
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol